Hiroko Gotoda
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
-
- Urologic and reproductive health conditions
Papers in
-
- Renal cell carcinoma treatment 4
- Prostate Cancer Diagnosis and Treatment 4
- Sarcoma Diagnosis and Treatment 2
- Prostate Cancer Treatment and Research 2
- Surgery 4
- Co-authors
- Shunji Muraoka (4 shared papers)Toshihiro Sato (2 shared papers)T. Furuno (2 shared papers)Satoshi Nagamori (2 shared papers)Nobuo Shinohara (2 shared papers)Yoji Nagashima (3 shared papers)Naoto Kuroda (3 shared papers)Yukichi Tanaka (1 shared paper)
- Journals
- Pathology International (3 papers)Diagnostic Pathology (1 paper)Biochemical and Biophysical Research Communications (1 paper)Cancer Medicine (1 paper)Diagnostic Cytopathology (1 paper)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Hiroko Gotoda
19 papers receiving 369 citations
Peers
Comparison fields: 5 of 37
- Pulmonary and Respiratory Medicine 245
- Rheumatology 40
- Physiology 44
- Genetics 49
- Public Health, Environmental and Occupational Health 44
Countries citing papers authored by Hiroko Gotoda
This map shows the geographic impact of Hiroko Gotoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Gotoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Gotoda more than expected).
Fields of papers citing papers by Hiroko Gotoda
This network shows the impact of papers produced by Hiroko Gotoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Gotoda. The network helps show where Hiroko Gotoda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Gotoda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 81 | |
| 2 | 2003 | 55 | |
| 3 | 2000 | 49 | |
| 4 | 2011 | 45 | |
| 5 | 2005 | 34 | |
| 6 | 2015 | 24 | |
| 7 | 2017 | 15 | |
| 8 | 2015 | 14 | |
| 9 | 2013 | 12 | |
| 10 | 1996 | 9 | |
| 11 | 2017 | 8 | |
| 12 | 2018 | 8 | |
| 13 | 2016 | 7 | |
| 14 | 2018 | 6 | |
| 15 | [Clinical effect of postoperative adjuvant chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT]. | 1991 | 3 |
| 16 | 2016 | 3 | |
| 17 | 2020 | 1 | |
| 18 | 2012 | 1 | |
| 19 | 2010 | 1 | |
| 20 | 2020 | 0 |
About Hiroko Gotoda
Hiroko Gotoda is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Epidemiology, Rheumatology and Physiology, having authored 22 papers that have together received 376 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Renal and related cancers (2 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Prostate Cancer Treatment and Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (245 citations), Rheumatology (40 citations), Physiology (44 citations), Genetics (49 citations) and Public Health, Environmental and Occupational Health (44 citations). Hiroko Gotoda has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Shunji Muraoka, Toshihiro Sato, T. Furuno, Satoshi Nagamori, Nobuo Shinohara, Yoji Nagashima, Naoto Kuroda, Yukichi Tanaka, Makiko Ohyama and Rieko Ijiri. Their work appears in journals such as Pathology International, Diagnostic Pathology, Biochemical and Biophysical Research Communications, Cancer Medicine and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.